Subtopic Deep Dive

Galectin Glycosylation Recognition
Research Guide

What is Galectin Glycosylation Recognition?

Galectin glycosylation recognition refers to the specific binding of galectins to β-galactoside-containing glycans, enabling immune cell interactions and cancer cell recognition through glycan array screening and structural studies.

Galectins recognize complex oligosaccharides via frontal affinity chromatography and printed covalent glycan arrays comprising 200 synthetic and natural sequences (Blixt et al., 2004, 1089 citations; Hirabayashi et al., 2002, 927 citations). This specificity modulates T-cell apoptosis and immune tolerance (Perillo et al., 1995, 1063 citations; Rabinovich and Toscano, 2009, 885 citations). Over 10 key papers since 1995 detail glycan-galectin lattices in disease contexts.

Curated Papers

Key Challenges

Why It Matters

Galectin-glycan decoding identifies cancer-associated glycosylation changes, guiding targeted therapies (Stowell et al., 2015, 861 citations). In immune tolerance, galectin-1 binding to T-cell glycans induces apoptosis, suppressing autoimmunity (Perillo et al., 1995; Demetriou et al., 2001, 892 citations). Glycan arrays profile galectin ligands for drug design, impacting nephrology and oncology (Reily et al., 2019, 2008 citations; Blixt et al., 2004).

Key Research Challenges

Glycan Structural Heterogeneity

Natural glycans exhibit branching and sialylation variations that complicate galectin binding specificity mapping (Hirabayashi et al., 2002). Frontal affinity chromatography reveals preferences but misses dynamic lattice effects (Hirabayashi et al., 2002, 927 citations). Over 200 glycan sequences require high-throughput screening for comprehensive profiling (Blixt et al., 2004).

Disease-Linked Glycan Alterations

Cancer induces N-glycosylation shifts via Mgat5, altering galectin recognition and immune evasion (Demetriou et al., 2001; Stowell et al., 2015). Profiling these changes demands mutant engineering and structural biology (Stowell et al., 2015, 861 citations). Validation across patient samples remains inconsistent (Reily et al., 2019).

Lattice Interaction Dynamics

Galectins form multivalent lattices on cell surfaces, but isolating individual glycan contributions challenges specificity studies (Rabinovich and Toscano, 2009). Glycan arrays capture binding but not lattice kinetics (Blixt et al., 2004). Structural mutants are needed to dissect these networks (Yang et al., 2008).

Essential Papers

Glycosylation in health and disease

Colin Reily, Tyler J. Stewart, Matthew B. Renfrow et al. · 2019 · Nature Reviews Nephrology · 2.0K citations

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins

Ola Blixt, Steve Head, Tony S. Mondala et al. · 2004 · Proceedings of the National Academy of Sciences · 1.1K citations

Here we describe a glycan microarray constructed by using standard robotic microarray printing technology to couple amine functionalized glycans to an amino-reactive glass slide. The array comprise...

Apoptosis of T cells mediated by galectin-1

Nancy L. Perillo, Karen E. Pace, Jeffrey J. Seilhamer et al. · 1995 · Nature · 1.1K citations

Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion

Teresa L. M. Thurston, Michal P. Wandel, Natalia von Muhlinen et al. · 2012 · Nature · 993 citations

Oligosaccharide specificity of galectins: a search by frontal affinity chromatography

Jun Hirabayashi, Tomomi Hashidate, Yoichiro Arata et al. · 2002 · Biochimica et Biophysica Acta (BBA) - General Subjects · 927 citations

TIM3 comes of age as an inhibitory receptor

Yochai Wolf, Ana C. Anderson, Vijay K. Kuchroo · 2019 · Nature reviews. Immunology · 898 citations

Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation

Michael Demetriou, Maria Granovsky, Sue Quaggin et al. · 2001 · Nature · 892 citations

Reading Guide

Foundational Papers

Start with Blixt et al. (2004, 1089 citations) for glycan array methods and Perillo et al. (1995, 1063 citations) for galectin-1 functional binding; then Hirabayashi et al. (2002, 927 citations) for specificity ranking.

Recent Advances

Study Reily et al. (2019, 2008 citations) on glycosylation in disease and Stowell et al. (2015, 861 citations) on cancer glycans for latest applications.

Core Methods

Core techniques: printed covalent glycan arrays (Blixt et al., 2004), frontal affinity chromatography (Hirabayashi et al., 2002), and N-glycosylation analysis via Mgat5 mutants (Demetriou et al., 2001).

How PapersFlow Helps You Research Galectin Glycosylation Recognition

Discover & Search

Research Agent uses searchPapers and exaSearch to query 'galectin glycan array specificity cancer', retrieving Blixt et al. (2004) as top hit with 1089 citations. citationGraph maps connections to Hirabayashi et al. (2002) and Perillo et al. (1995); findSimilarPapers expands to 50+ related works on glycosylation in oncology.

Analyze & Verify

Analysis Agent applies readPaperContent to extract glycan sequences from Blixt et al. (2004) abstracts, then runPythonAnalysis with pandas to quantify binding motifs across 10 papers. verifyResponse via CoVe cross-checks claims against GRADE scoring, confirming galectin-1 specificity (Perillo et al., 1995) with statistical verification of citation overlap.

Synthesize & Write

Synthesis Agent detects gaps in lattice dynamics coverage across Demetriou et al. (2001) and Rabinovich (2009), flagging contradictions in glycan roles. Writing Agent uses latexEditText and latexSyncCitations to draft review sections, latexCompile for PDF, and exportMermaid to visualize galectin-glycan lattices as flow diagrams.

Use Cases

"Analyze glycan binding data from galectin arrays in cancer papers using Python."

Research Agent → searchPapers('galectin glycan array cancer') → Analysis Agent → readPaperContent(Blixt 2004) → runPythonAnalysis(pandas motif counting, matplotlib heatmaps) → researcher gets quantified specificity tables and glycan preference plots.

"Draft LaTeX review on galectin glycosylation in immune tolerance."

Synthesis Agent → gap detection(Demetriou 2001, Rabinovich 2009) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → researcher gets compiled PDF with synced references and galectin lattice figure.

"Find code for galectin glycan modeling from recent papers."

Research Agent → searchPapers('galectin glycosylation simulation code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets repo links with glycan docking scripts linked to Hirabayashi et al. (2002) methods.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'galectin glycosylation cancer', structures report with citationGraph on Blixt (2004) clusters, and GRADE-grades glycan specificity claims. DeepScan applies 7-step CoVe to verify lattice models from Rabinovich (2009), checkpointing against Perillo (1995). Theorizer generates hypotheses on mutant designs for cancer glycans from Demetriou (2001) data.

Try Doxa for Galectin Glycosylation Recognition Research

Frequently Asked Questions

What defines galectin glycosylation recognition?

Galectins bind β-galactoside glycans with specificity profiled by glycan arrays and frontal affinity chromatography (Blixt et al., 2004; Hirabayashi et al., 2002).

What methods probe galectin-glycan specificity?

Printed covalent glycan arrays test 200 sequences; frontal affinity chromatography ranks oligosaccharide affinity (Blixt et al., 2004, 1089 citations; Hirabayashi et al., 2002, 927 citations).

What are key papers on this topic?

Blixt et al. (2004, 1089 citations) on glycan arrays; Perillo et al. (1995, 1063 citations) on galectin-1 T-cell apoptosis; Hirabayashi et al. (2002, 927 citations) on specificity.

What open problems exist?

Dynamic lattice interactions and disease-specific glycan shifts require advanced mutants and kinetics studies (Rabinovich and Toscano, 2009; Stowell et al., 2015).